Search Results - "Ashe, Karen M."
-
1
Substrate reduction augments the efficacy of enzyme therapy in a mouse model of Fabry disease
Published in PloS one (24-11-2010)“…Fabry disease is an X-linked glycosphingolipid storage disorder caused by a deficiency in the activity of the lysosomal hydrolase α-galactosidase A (α-gal)…”
Get full text
Journal Article -
2
Iminosugar-based inhibitors of glucosylceramide synthase increase brain glycosphingolipids and survival in a mouse model of Sandhoff disease
Published in PloS one (29-06-2011)“…The neuropathic glycosphingolipidoses are a subgroup of lysosomal storage disorders for which there are no effective therapies. A potential approach is…”
Get full text
Journal Article -
3
Iminosugar-based inhibitors of glucosylceramide synthase prolong survival but paradoxically increase brain glucosylceramide levels in Niemann–Pick C mice
Published in Molecular genetics and metabolism (01-04-2012)“…Niemann Pick type C (NPC) disease is a progressive neurodegenerative disease caused by mutations in NPC1 or NPC2, the gene products of which are involved in…”
Get full text
Journal Article -
4
Food Insecurity and Obesity: Exploring the Role of Social Support
Published in Journal of women's health (Larchmont, N.Y. 2002) (01-05-2018)“…Women are disproportionately affected by both obesity and food insecurity. Food insecurity occurs when there is limited ability to acquire adequate foods. It…”
Get more information
Journal Article -
5
Efficacy of Enzyme and Substrate Reduction Therapy with a Novel Antagonist of Glucosylceramide Synthase for Fabry Disease
Published in Molecular medicine (Cambridge, Mass.) (30-04-2015)“…Fabry disease, an X-linked glycosphingolipid storage disorder, is caused by the deficient activity of α-galactosidase A (α-Gal A). This results in the…”
Get full text
Journal Article -
6
Exposure to Weight Management Counseling Among Students at 8 U.S. Medical Schools
Published in American journal of preventive medicine (01-05-2021)“…Clinical guidelines support physician intervention consistent with the Ask, Advise, Assess, Assist, Arrange framework for adults who have obesity. However,…”
Get full text
Journal Article -
7
α-Galactosidase A knockout mice: progressive organ pathology resembles the type 2 later-onset phenotype of Fabry disease
Published in The American journal of pathology (01-03-2015)“…Fabry disease is an X-linked lysosomal storage disease caused by deficient activity of α-galactosidase A and the resultant systemic accumulation of…”
Get full text
Journal Article -
8
Students’ Report of Preceptor Weight Management Counseling at Eight U.S. Medical Schools
Published in American journal of preventive medicine (01-11-2018)“…Primary care providers, using brief counseling, can help patients increase motivation to initiate or maintain weight loss, improve diet, and increase physical…”
Get full text
Journal Article -
9
Systemic Administration of AAV8-α-galactosidase A Induces Humoral Tolerance in Nonhuman Primates Despite Low Hepatic Expression
Published in Molecular therapy (01-11-2011)“…In mice, liver-restricted expression of lysosomal enzymes from adeno-associated viral serotype 8 (AAV8) vectors results in reduced antibodies to the expressed…”
Get full text
Journal Article -
10
Merits of Combination Cortical, Subcortical, and Cerebellar Injections for the Treatment of Niemann-Pick Disease Type A
Published in Molecular therapy (01-10-2012)“…Niemann-Pick disease Type A (NPA) is a neuronopathic lysosomal storage disease (LSD) caused by the loss of acid sphingomyelinase (ASM). The goals of the…”
Get full text
Journal Article -
11
Design and rationale of the medical students learning weight management counseling skills (MSWeight) group randomized controlled trial
Published in Contemporary clinical trials (01-01-2018)“…Physicians have an important role addressing the obesity epidemic. Lack of adequate teaching to provide weight management counseling (WMC) is cited as a reason…”
Get full text
Journal Article -
12
α-Galactosidase A Knockout Mice
Published in The American journal of pathology (01-03-2015)“…Fabry disease is an X-linked lysosomal storage disease caused by deficient activity of α-galactosidase A and the resultant systemic accumulation of…”
Get full text
Journal Article -
13
Inhibition of glycogen biosynthesis via mTORC1 suppression as an adjunct therapy for Pompe disease
Published in Molecular genetics and metabolism (01-08-2010)“…Pompe disease, also known as glycogen storage disease (GSD) type II, is caused by deficiency of lysosomal acid α-glucosidase (GAA). The resulting glycogen…”
Get full text
Journal Article -
14
Vesicular monoamine transporter-1 (VMAT-1) mRNA and immunoreactive proteins in mouse brain
Published in Neuro-endocrinology letters (2011)“…Vesicular monoamine transporter 1 (VMAT-1) mRNA and protein were examined (1) to determine whether adult mouse brain expresses full-length VMAT-1 mRNA that can…”
Get more information
Journal Article -
15
217. Comparison of Hepatic Vein and Peripheral Vein Delivery of an AAV2/8 Vector Encoding Human a-Galactosidase A to Rhesus Macaques
Published in Molecular therapy (01-05-2006)“…In murine models of lysosomal storage diseases, sustained hepatocyte-restricted expression and secretion of the therapeutic enzyme is capable of correcting the…”
Get full text
Journal Article -
16
Medical Student Weight Bias: the Relationship of Attitudinal Constructs Related to Weight Management Counseling
Published in Medical science educator (01-06-2018)“…Obesity is a prevalent disease that is often a source of stigmatization. Weight bias has been documented in healthcare settings and associated with less…”
Get full text
Journal Article -
17
Merits of Combination Cortical, Subcortical, and Cerebellar Injections for the Treatment of Niemann-Pick Disease Type A
Published in Molecular therapy (01-10-2012)“…Niemann-Pick disease Type A (NPA) is a neuronopathic lysosomal storage disease (LSD) caused by the loss of acid sphingomyelinase (ASM). The goals of the…”
Get full text
Journal Article -
18
Systemic Administration of AAV8-[alpha]-galactosidase A Induces Humoral Tolerance in Nonhuman Primates Despite Low Hepatic Expression
Published in Molecular therapy (01-11-2011)“…In mice, liver-restricted expression of lysosomal enzymes from adeno-associated viral serotype 8 (AAV8) vectors results in reduced antibodies to the expressed…”
Get full text
Journal Article